Lipid Metabolism in Late-Onset Alzheimer’s Disease Differs from Patients Presenting with Other Dementia Phenotypes

Abnormal cerebrospinal fluid (CSF) levels of β-amyloid peptides (Aβ(42)) and Tau and cognitive decline are typical characteristics of Alzheimer’s disease (AD). Since dysregulation in lipid metabolism accompanies abnormal amyloid formation, we quantified glycerophospholipids (GP) and sphingolipids (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarrafpour, Syena, Ormseth, Cora, Chiang, Abby, Arakaki, Xianghong, Harrington, Michael, Fonteh, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603882/
https://www.ncbi.nlm.nih.gov/pubmed/31195602
http://dx.doi.org/10.3390/ijerph16111995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603882/
https://www.ncbi.nlm.nih.gov/pubmed/31195602
http://dx.doi.org/10.3390/ijerph16111995

Ejemplares similares